Medicines for Europe
Shaping Europe’s Future of Affordable and Sustainable Medicines
Represents 400+ pharma companies across Europe, promoting access, sustainability, and innovation through generics, biosimilars, and etc.
Opportunities
What we’re looking for?
Biopharmaceuticals
Regenerative Medicine & Cell Therapy
Estimated Budget
Project‑based Negotiation
Partnership Types
CDMO / CMO
Co-Development / Joint R&D
Market Region
Europe & Africa
Company Overview
Medicines for Europe
Belgium
Founded in 1993 as the European Generics Medicines Association, represents the European pharmaceutical industry focused on generic, biosimilar, and value-added medicines. Its diverse membership includes leading manufacturers, national associations, and supply-chain partners across Europe. As the continent’s key voice for affordable and sustainable medicines, it drives access, regulatory alignment, and industry competitiveness across 30+ European countries.
Established Since
1993
Annual Revenue
Under $10 million
Employees
30
Business Attribute
Industry Association
Business Nature
Biotech/ Diagnostics/ Pharmaceutical/ Regenerative Medicine/ Preventive Medicine
Company Highlights
1
Europe’s Voice for Affordable and Resilient Medicines
Unites Europe's leading generic, biosimilar, and value-added medicine producers; drives access, affordability, and industrial resilience across 30+ European countries.
Market Presence
30+ European countries, ex. Belgium, Denmark, France, Germany, Italy, Netherlands, Spain, etc.
Brands in Charge for Distribution
Medicines for Europe
Strategic Focus Areas
Focuses on access to affordable medicines, supply resilience, sustainable markets, regulatory reform, green manufacturing, and strengthening Europe’s pharmaceutical competitiveness globally.
Contact Info
Start the Conversation About Our Next Project
buyer name
job title
contact location
Contact Time Zone
UTC+02:00
(Europe / Amsterdam)
(Europe / Amsterdam)
Language
English